openPR Logo
Press release

Inflammatory Bowel Disease (IBD) Treatment Market will Exhibit a Steady 2.6% CAGR through 2025

04-02-2018 03:16 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Inflammatory Bowel Disease (IBD) Treatment Market will Exhibit

Competition is expected to remain high from 2017 to 2025 in the global inflammatory bowel disease (IBD) treatment market. During this time, the market will witness a slew of launches as manufacturers invest in the development of novel therapeutics. According to a new study by Transparency Market Research (TMR), a paradigm shift toward biosimilar and biologic drugs is expected, which will offer a fresh burst of opportunities to the global inflammatory bowel disease treatment market.

The market players are also likely to benefit from approval of novel drugs and treatment methods. With biopharmaceutical companies injecting more money in research and development activities, more number of products are likely in different stages of clinical approvals. Through the course of the aforementioned forecast period, these medicines are likely to get commercialized, thereby giving impetus to the respective companies. In the study, TMR has highlighted companies including Shire Plc., Valeant Pharmaceuticals International, Inc., Allergan plc, Pfizer, Inc., Janssen Biotech, Inc. (Johnson & Johnson), Takeda Pharmaceutical Company Limited., AbbVie, Inc., Novartis AG, UCB Inc., and Biogen Inc.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1473

TMR pegged the global inflammatory bowel disease treatment market at US$10.52 bn in 2016. Rising at a steady 2.6% CAGR between 2017 and 2025, the market is likely to value US$14.83 bn by the end of 2025. In 2016, North America led the global IBD market, which is attributable to the rising incidence of the disease witnessed among men and women alike in the region. As per the report, the incidence of Ulcerative colitis and Crohn’s disease is high in US and Canada, which fuels the demand for IBD treatment in North America. Also, based on drug class, the market was dominated by TNF inhibitors in 2016. Adalimumab, Vedolizumab, and Infliximab are the most commonly used TNF inhibitors, finds TMR.

Request for TOC @ https://www.transparencymarketresearch.com/report-toc/1473

Rising Incidence of IBDs to Push Demand for Effective Treatments

According to the Center for Disease Control and Prevention (CDC), nearly 3.1 million people in the US (which is around 1.3% of the country’s entire population) were either diagnosed with Ulcerative Colitis or Crohn’s Disease. Also it is estimated that nearly 70,000 new cases of IBD are reported in the US every year. Given the scenario the hospitalization rate has surged in America, in turn creating growth prospects for the inflammatory bowel disease treatment market. Besides this, the recent product approvals by the European Medicines Agency and other similar organization has enabled the market gain significant momentum.

Rising Availability of Biosimilar Versions Threatens Leading Drug Producers

Growth rate is likely to remain steady for the global inflammatory bowel disease treatment market in the coming years, driven by product development and approvals, rising incidence of IBD worldwide, and arrival of novel medications. On the flip side, the high availability of biosimilar copies of popular drugs may create hindrances for established market players. For instance, a few studies conducted in 2017 have suggested that biosimilar copies of AbbVie’s Humira are speeding toward the market.

Obtain Report Details @ https://www.transparencymarketresearch.com/inflammatory-bowel-disease.html

Similarly a version of Johnson & Johnson’s Remicade is already available in the market. “Studies reveal that while biosims may become a rather important option for the treatment of first-line biological patients, soon they may require further treatment, which will create lucrative prospects for therapeutics based on novel mechanism,” said a lead TMR analyst.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inflammatory Bowel Disease (IBD) Treatment Market will Exhibit a Steady 2.6% CAGR through 2025 here

News-ID: 1000606 • Views: 295

More Releases from Transparency Market Research

High Build Rust Stabilizer with Reinforced Glass Flake Coating Market - Future G …
High Build Rust Stabilizer with Reinforced Glass Flake Coating Market: Introduction Transparency Market Research delivers key insights on the global high build rust stabilizer with reinforced glass flake coating market. In terms of revenue, the global high build rust stabilizer with reinforced glass flake coating market is estimated to expand at a CAGR of ~6% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts
Latin America Hyaluronic Acid Dermal Filler Market - Future Demand Strategies 20 …
Latin America Hyaluronic Acid Dermal Filler Market: Introduction In terms of volume, the hyaluronic acid dermal filler market in Latin America is anticipated to expand at a CAGR of ~5% from 2020 to 2030. Strong growth of the hyaluronic acid dermal filler market in Latin America can be ascribed to the rise in medical tourism in the region. The cost of dermal filler procedure is lower in Latin America than that
Isoprenol Market Analysis, Segments, Growth and Value Chain 2020-2030
Isoprenol Market: Introduction In terms of value, the global isoprenol market is anticipated to expand at a CAGR of 7% from 2020 to 2030. Isoprenol is primarily used in pharmaceutical, aroma chemical, agrochemical, and polymers, applications. It is predominantly employed as a building block for aromatic chemicals. Isoprenol is also gaining popularity in the global market, owing to its beneficial physical and chemical properties. Read report Overview: https://www.transparencymarketresearch.com/isoprenol-market.html Isoprenol is widely employed in
PP Capacitor Films Market Analysis, Segments, Growth and Value Chain 2020-2030
Asia Pacific PP Capacitor Films Market: Introduction Transparency Market Research delivers key insights on the PP capacitor films market in Asia Pacific. In terms of revenue, the PP capacitor films market in Asia Pacific is estimated to expand at a CAGR of ~6% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in its report on the PP capacitor films market in Asia Pacific. The

All 5 Releases


More Releases for IBD

Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per
Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 201 …
Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India. Request a Free Sample of our
Germany IBD Therapeutics Market will experience a noticeable growth during the f …
Germany IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.4% during the forecast period. The growing IBD patient population in the region is one of the major driving forces for the growth of the market in the country. According to the national institutes of health, the prevalence of Crohn's disease in Germany was estimated to be 322 per 100,000 in Germany in 2018. Moreover, the
Canada IBD Therapeutics Market, Industry Trends, Size, Competitive Analysis and …
Canada IBD Therapeutics market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,
Global Inflammatory Bowel Disease (IBD) Treatment Market to Grow at 2.6% CAGR th …
A new thorough study titled “Inflammatory Bowel Disease (IBD) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has recently been submitted to the database of Market Research Reports Search Engine (MRRSE). The global inflammatory bowel disease treatment market is projected to grow at 2.6% CAGR through 2025. In terms of revenue, the market is anticipated to reach nearly US$ 15 Bn in revenues. Request Sample Copy